(Press-News.org) NEW ORLEANS, LOUISIANA – Ochsner Health has announced the recipients of the 38th Annual Alton Ochsner Award Relating Smoking and Disease. They are Ken J. Kellar, Ph.D, Professor of Pharmacology, Georgetown University Medical Center, and Ryan E. Hibbs, Ph.D., Professor of Neurobiology, University of California San Diego.
This prestigious honor bestowed by Ochsner Health recognizes scientists who have made major contributions in understanding the relationship between smoking and disease, along with the development of innovative treatment modalities. The award is named in honor of Alton Ochsner, MD, the co-founder of the Ochsner Clinic (now known as Ochsner Health) based in New Orleans. In 1939, Dr. Ochsner published the first evidence indicating that tobacco smoking was the major cause of lung cancer.
Dr. Kellar pioneered the study of nicotine receptors and discovered important aspects of their biology and regulation—including receptor up-regulation by chronic nicotine.
“It is an honor to receive this award for my lab’s work investigating nicotine receptors,” said Dr. Kellar. “The ability to determine targets for the treatment of nicotine addiction is an important advancement in the fight against smoking-related disease.”
Dr. Hibbs performed detailed crystallographic and electron microscopy studies of nicotine receptors, which studied atomic-level molecular structures and revealed previously unappreciated aspects of their function. The work of both these scientists points the way for the development of more effective means of treating nicotine addiction and thereby reducing smoking and smoking-related disease.
“Understanding the function and makeup of nicotine receptors is key to making advancements in the treatment of nicotine addiction,” said Dr. Hibbs. “It’s an honor to be selected for this award and to be recognized for advancing efforts to reduce smoking rates in populations throughout the United States.”
As the 2023 honorees, Drs. Kellar and Hibbs will each receive a $7500 honorarium, an award medallion, and a plaque describing their key research findings.
Smoking cessation remains a priority for the collaborative Healthy State initiative, a collaboration between Ochsner and partners in government, non-profit and business organizations to create healthier, happier and more productive communities, with health equity at the forefront of these efforts. Together, Healthy State members from every sector bring resources to underserved communities in order to better understand the impact of social conditions on health and to utilize data, technology and innovation to improve outcomes.
“Ochsner Health is honored to support researchers who make critical advancements in innovative treatments of complex healthcare issues, especially those related to smoking cessation and disease prevention, because we know collaboration is key to improving the health and wellness of our communities,” said Leonardo Seoane, MD, Chief Academic Officer for Ochsner Health. “We commend Drs. Kellar and Hibbs for their critical advancements in understanding the regulation and function of nicotine receptors as they relate to cessation efforts.”
For a list of previous Ochsner Award recipients click here: https://research.ochsner.org/opportunities/research-awards/the-alton-ochsner-award-relating-smoking-and-disease
###
About Ochsner Health
Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating more than 80 years of service, it leads nationally in cancer care, cardiology, neurosciences, liver and kidney transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children’s hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities through its Healthy State by 2030 initiative, a bold and collaborative plan to realize a healthier Louisiana. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022. It has more than 37,000 employees and over 4,700 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 46 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. In 2022, Ochsner Health treated more than 1.4 million people from every state and 62 countries. As Louisiana’s top healthcare educator of physicians, Ochsner Health and its partners educate thousands of healthcare professionals annually. To learn more, visit https://www.ochsner.org/.
END
In the last few years, breast reduction procedures in the U.S. have become increasingly common. According to the American Society of Plastic Surgeons, nearly 100,000 breast reduction procedures were performed in 2020.
This procedure involves a high-tension T-Junction suture in which three incisions meet, forming the shape of a T. Larger breast reductions with longer incisions may have a higher risk of complications and wound healing problems at the T-Junction, which represent 13 to 39% of wound breakdown. It’s known that decreased blood flow to the wound, which then reduces the amount of oxygen to the area, promotes wound breakdown.
Looking to improve ...
It’s human nature to be judgmental. But why do we place less blame on someone, or give more praise, if we find out that person had a history of suffering in childhood? In a recent study, University of Missouri researchers discovered why someone’s childhood adversity influences how others judge their behavior.
The finding contributes to a growing body of evidence that suggests judgments of praise and blame are “asymmetrically sensitive” to certain types of information about someone’s life history, said Philip Robbins, associate professor and chair of the Department of Philosophy.
“In the case of negative or anti-social behavior, we ...
East Hanover, August 22, 2023 — Since the COVID-19 pandemic, gains in the labor market for people with disabilities have been at near all-time highs. Expert speakers at last Friday’s nTIDE Deeper Dive Lunch & Learn Webinar provided results from an in-depth University of New Hampshire research study, which took a closer look at the unprecedented surge in employment-to-population ratio among most of the six disability subgroups identified by the U.S. Bureau of Labor Statistics (BLS). Possible driving factors behind this employment transformation were also explored.
nTIDE Deeper Dive Lunch & Learn Webinar is presented by Kessler Foundation ...
If coal and natural gas power generation were 2% more efficient, then, every year, there could be 460 million fewer tons of carbon dioxide released and 2 trillion fewer gallons of water used. A recent innovation to the steam cycle used in fossil fuel power generation could achieve this.
Researchers at the University of Illinois Urbana-Champaign have developed a coating for steam condensers used in fossil fuel steam-cycle generation that is made with fluorinated diamond-like carbon, or F-DLC. The researchers reported in the journal Nature Communications that this coating could boost the overall process efficiency ...
NEW YORK, NY--Ask any neurologist: Parkinson’s disease is a brain disorder. The conspicuous symptoms of Parkinson’s disease—uncontrollable tremors, slowed down motions, and the feeling that one’s feet are stuck to the ground—all stem from the loss of neurons in a region of the brain that helps control movement.
But many researchers believe that the neurodegenerative disorder may get started far away from the brain—in the gut—and years before the first neurological signs appear.
New findings by Columbia researchers David Sulzer, ...
Freshwater ecosystems account for half of global emissions of methane, a potent greenhouse gas that contributes to global warming. Rivers and streams, especially, are thought to emit a substantial amount of that methane, but the rates and patterns of these emissions at global scales remain largely undocumented.
An international team of researchers, including University of Wisconsin–Madison freshwater ecologists, has changed that with a new description of the global rates, patterns and drivers of methane emissions from ...
INDIANAPOLIS – A new study by Indiana University School of Medicine researchers uses more genetically diverse mouse models to study the accumulation and spread of abnormal tau protein deposits in the brain—a known sign of Alzheimer’s disease and several other neurodegenerative diseases. The study’s findings, recently published in the Journal of Experimental Medicine, could lead to better research models that improve understanding of how different genetic backgrounds influence neurodegenerative disease development and treatment needs.
“As ...
A study conducted by researchers affiliated with the University of São Paulo (USP) in Brazil concluded that particles of glitter can hinder the growth of organisms at the base of aquatic ecosystems, such as cyanobacteria (blue-green algae), which play a key role in the biogeochemical cycles of water and soil, as well as being eaten by other organisms. An article on the study is published in the journal Aquatic Toxicology.
Ubiquitous in makeup, nail polish, holiday decorations, greeting cards, Carnival costumes and many other places, glitter sticks to skin and clothes and requires a lot of effort to remove. It is made up of microplastics, tiny particles ...
Paper Title: Outpatient cervical ripening and labor induction with low-dose vaginal misoprostol reduces the interval to delivery: A systematic review and network meta-analysis
Journal: American Journal of Obstetrics and Gynecology, July 2023
Authors: Joanne L. Stone, MD, MSHCDL, Professor and System Chair of the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai; Rachel Meislin, MD, Maternal-Fetal Medicine Fellow at Mount Sinai Hospital; and other coauthors.
Bottom Line: While prior research and analysis have evaluated methods of outpatient labor ...
HOUSTON (Aug. 22, 2023) — The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute® (THI) a two-year, $1.14 million grant to develop a novel, first-in-class drug to treat cardiovascular disease (CVD) as a significant improvement to current treatment regimens — specifically for adverse events arising from atherosclerosis.
Cardiovascular disease is the leading cause of death worldwide, with the Centers for Disease Control and Prevention (CDC) estimating that one person dies from CVD every 33 seconds in the United States, accounting for one in every five deaths in 2021.
CVD leads to heart ...
